The efficacy of the A740003, a P2X7 specific antagonist, in decreasing vessel inflammation further supports its role in atherosclerosis and gives a new chance for the local pharmacological targeting of atherosclerosis (113). The gene discussed is P2RX7; the disease is atherosclerosis.